The Effect of the Type of Membrane on Intradialytic Complications and Mortality in Crush Syndrome

Figures & data

Table 1  Demographical, biochemical, and hematological parameters of the groups

	All groups	Hemophan	Polysulfone	Combined
	(n = 45)	(n = 8)	(n = 18)	(n = 19)
Age (years)	33.9 ± 13.3	36.1 ± 13.4	37.2 ± 13.7	29.9 ± 12.4	NS
Sex (F/M)	24/21	5/3	10/8	9/10	NS
Time under rubble, hours	8.8 ± 3.8	10.3 ± 4.0	9.8 ± 4.4	7.5 ± 2.8	NS
BUN, mg/dL	81.0 ± 46.1	66.1 ± 24.1	89.1 ± 54.0	79.5 ± 45.3	NS
Creatinine, mg/dL	6.61 ± 3.54	3.81 ± 1.18	8.35 ± 4.05	6.13 ± 2.81	0.005
Potassium, meq/L	5.03 ± 1.28	5.09 ± 0.96	4.9 ± 1.55	5.07 ± 1.16	NS
Uric acid, mg/dL	7.1 ± 3.4	4.9 ± 1.1	8.0 ± 2.7	6.3 ± 4.5	NS
Calcium, mg/dL	7.1 ± 1.6	6.0 ± 1.7	7.7 ± 1.1	6.9 ± 1.9	NS
Phophorus, mg/dL	5.7 ± 1.7	5.4 ± 1.0	6.3 ± 1.3	4.9 ± 2.1	NS
CK, U/L	21977 ± 28167	42462 ± 38807	11910 ± 27833	24077 ± 19214	0.036
LDH, U/L	1582 ± 1249	1714 ± 1499	1678 ± 1490	1435 ± 894	NS
AST, U/L	1055 ± 1586	876 ± 752	849 ± 1192	1331 ± 2111	NS
ALT, U/L	414 ± 642	338 ± 314	525 ± 873	333 ± 446	NS
Albumin, g/dL	2.6 ± 0.5	2.2 ± 0.7	2.6 ± 0.4	2.7 ± 0.4	NS
Leucocyte, /mm^3	12261 ± 4755	12760 ± 4891	12705 ± 4697	11710 ± 4976	NS
Hct, %	27.7 ± 6.9	29.8 ± 8.4	27.1 ± 5.2	27.4 ± 7.8	NS
Trombocyte, /mm^3	174761 ± 84455	153200 ± 48710	211666 ± 105876	145473 ± 52306	0.042
Fever, ^oC	37.9 ± 0.8	38.7 ± 1.1	37.6 ± 0.5	38.2 ± 0.7	NS
Systolic BP, mmHg	140.8 ± 30.6	126.8 ± 41.4	149.4 ± 30.1	138.6 ± 24.4	NS
Diastolic BP, mmHg	83.5 ± 17.4	76.2 ± 28.6	85.0 ± 14.6	85.2 ± 13.7	NS
Number of dialysis sessions	8.8 ± 6.1	3.7 ± 4.7	8.2 ± 5.7	11.4 ± 5.7	0.006
Number of HD days	10.7 ± 8.5	2.6 ± 1.2	10.3 ± 8.2	13.7 ± 8.6	0.014
Catheter number/ patient	1.28 ± 0.5	1 ± 0	1.27 ± 0.46	1.42 ± 0.6	NS
Urinary output, mL/day	664 ± 1711	1207 ± 1386	223 ± 368	869 ± 2428	NS
Hypotensive episode/session (%)	45.4 ± 6.5	67.5 ± 20	54.1 ± 5.4	36.9 ± 7.3	NS
Coagulation/session (%)	26.4 ± 18.3	33.7 ± 10.4	43.1 ± 5.4	23.0 ± 3.6	NS
Death	5 (11.1%)	2 (25.0%)	1 (5.5%)	2 (10.5%)

Abbreviations: HD = hemodialysis, BP = blood pressure, Hct = hematocrit.

Table 2  Hemodialysis indications of the groups

	All patients	Hemofan group	Polysulfone group	Combined group
	(n = 45)	(n = 8)	(n = 18)	(n = 19)
Azotemia+hypervolemia+hyperkalemia	14	0	9	5
Azotemia+hypervolemia	13	3	5	5
Azotemia+hyperkalemia	7	1	3	3
Azotemia	10	4	1	5
Hypervolemia	1	0	0	1